Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
2.570
+0.140 (5.76%)
At close: Nov 1, 2024, 4:00 PM
2.590
+0.020 (0.78%)
After-hours: Nov 1, 2024, 4:45 PM EDT

Exagen Statistics

Total Valuation

Exagen has a market cap or net worth of $44.68 million. The enterprise value is $44.30 million.

Market Cap 44.68M
Enterprise Value 44.30M

Important Dates

The next confirmed earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date Nov 12, 2024
Ex-Dividend Date n/a

Share Statistics

Exagen has 17.39 million shares outstanding. The number of shares has increased by 3.16% in one year.

Shares Outstanding 17.39M
Shares Change (YoY) +3.16%
Shares Change (QoQ) +1.30%
Owned by Insiders (%) 13.10%
Owned by Institutions (%) 27.50%
Float 6.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.81
Forward PS 0.77
PB Ratio 2.54
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.78
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.32, with a Debt / Equity ratio of 1.37.

Current Ratio 4.32
Quick Ratio 3.83
Debt / Equity 1.37
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -7.08

Financial Efficiency

Return on equity (ROE) is -69.97% and return on invested capital (ROIC) is -19.91%.

Return on Equity (ROE) -69.97%
Return on Assets (ROA) -17.41%
Return on Capital (ROIC) -19.91%
Revenue Per Employee $316,536
Profits Per Employee -$96,726
Employee Count 179
Asset Turnover 1.00
Inventory Turnover 10.23

Taxes

In the past 12 months, Exagen has paid $33,000 in taxes.

Income Tax 33,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +50.29% in the last 52 weeks. The beta is 1.32, so Exagen's price volatility has been higher than the market average.

Beta (5Y) 1.32
52-Week Price Change +50.29%
50-Day Moving Average 2.88
200-Day Moving Average 2.16
Relative Strength Index (RSI) 42.53
Average Volume (20 Days) 16,674

Short Selling Information

The latest short interest is 23,450, so 0.13% of the outstanding shares have been sold short.

Short Interest 23,450
Short Previous Month 15,746
Short % of Shares Out 0.13%
Short % of Float 0.35%
Short Ratio (days to cover) 0.98

Income Statement

In the last 12 months, Exagen had revenue of $56.66 million and -$17.31 million in losses. Loss per share was -$0.97.

Revenue 56.66M
Gross Profit 33.51M
Operating Income -15.81M
Pretax Income -17.28M
Net Income -17.31M
EBITDA -13.81M
EBIT -15.81M
Loss Per Share -$0.97
Full Income Statement

Balance Sheet

The company has $24.48 million in cash and $24.10 million in debt, giving a net cash position of $383,000 or $0.02 per share.

Cash & Cash Equivalents 24.48M
Total Debt 24.10M
Net Cash 383,000
Net Cash Per Share $0.02
Equity (Book Value) 17.59M
Book Value Per Share 1.01
Working Capital 31.35M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.03 million and capital expenditures -$330,000, giving a free cash flow of -$6.36 million.

Operating Cash Flow -6.03M
Capital Expenditures -330,000
Free Cash Flow -6.36M
FCF Per Share -$0.37
Full Cash Flow Statement

Margins

Gross margin is 59.13%, with operating and profit margins of -27.90% and -30.56%.

Gross Margin 59.13%
Operating Margin -27.90%
Pretax Margin -30.50%
Profit Margin -30.56%
EBITDA Margin -24.37%
EBIT Margin -27.90%
FCF Margin -11.18%

Dividends & Yields

Exagen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.16%
Shareholder Yield -3.16%
Earnings Yield -38.75%
FCF Yield -14.22%

Analyst Forecast

The average price target for Exagen is $7.00, which is 172.37% higher than the current price. The consensus rating is "Buy".

Price Target $7.00
Price Target Difference 172.37%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 14.15%
EPS Growth Forecast (5Y) -13.30%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Exagen has an Altman Z-Score of -6.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -6.62
Piotroski F-Score 3